Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q2 2023 call → NOWe need to determine if management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is already visible. The key is: a proven instance, copies being stood up now, and demand already identified at the destination. From the transcript, Mike Rice discusses a new GMP Media Manufacturing Center of Excellence. He says: "we made progress on our initial assessment of potential locations to build and validate a de novo Cell Processing media production facility. The objective of this initiative is to derisk potential environmental disruptions to our Bothell and Indy facilities, but also to build sufficient additional capacity to meet anticipated demand for our proprietary high-margin recurring revenue media products. While the time line is not yet locked, it’s likely this new facility will come online toward the end of 2025." This is about building a new facility. But is it a copy of an existing proven instance? The existing facilities are Bothell and Indy. The new facility is to add capacity and derisk. However, the transcript does not indicate that the new facility is being stood up now. It says "initial assessment of potential locations" and "time line is not yet locked" and "likely come online toward the end of 2025." That suggests it's in planning, not under construction. Also, demand is described as "anticipated demand" not already visible at the destination. So this does not meet the criteria. Another possibility: the evo Cold Chain rentals. Mike mentions "evo shipments continue to grow as more end customers are onboarded by our courier partners." And a global pharma company is evaluating and validating the evo platform, expecting to ramp in last half of 2024. That is not a copy being stood up now; it's a product line expansion. Also, SciSafe biostorage: "we continue to evaluate a list of potential expansion locations to increase our global biostorage capacity footprint." That is also planning, not construction. Thus, there is no description of a proven instance being replicated now with demand already visible. The company is divesting freezers, focusing on consumables, but not describing a replication of a proven unit. Therefore, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.